Suzuken Co., Ltd. (TYO:9987)
5,053.00
-30.00 (-0.59%)
Jun 3, 2026, 12:55 PM JST
Suzuken Revenue
In the fiscal year ending March 31, 2026, Suzuken had annual revenue of 2.49T JPY with 3.61% growth. Suzuken had revenue of 601.02B in the quarter ending March 31, 2026, with 7.08% growth.
Revenue
2.49T
Revenue Growth
+3.61%
P/S Ratio
0.14
Revenue / Employee
192.42M
Employees
12,923
Market Cap
343.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.49T | 86.70B | 3.61% |
| Mar 31, 2025 | 2.40T | 13.46B | 0.56% |
| Mar 31, 2024 | 2.39T | 71.67B | 3.10% |
| Mar 31, 2023 | 2.31T | 82.05B | 3.67% |
| Mar 31, 2022 | 2.23T | 104.56B | 4.91% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.51T |
| Alfresa Holdings | 3.10T |
| Otsuka Holdings | 2.52T |
| Chugai Pharmaceutical | 1.29T |
| HOYA Corporation | 947.75B |
| Sundrug | 842.51B |
| Nipro | 660.54B |
| Kusuri No Aoki Holdings | 552.39B |